jetcityimage/iStock Editorial through Getty Pictures
Eli Lilly (NYSE:LLY) should pay $183.7M as damages in a lawsuit alleging that the Indiana-based drugmaker defrauded the Medicaid drug pricing program, a federal appeals court docket dominated on Thursday, upholding a decrease court docket ruling.
In August 2022, a federal jury ordered
